Israel Englander Pmv Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 363,969 shares of PMVP stock, worth $545,953. This represents 0.0% of its overall portfolio holdings.

Number of Shares

363,969

Previous 758,740 52.03%

Holding current value

$545,953

Previous $1.23 Million 55.9%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.44 - $1.69 $568,470 - $667,162	-394,771 Reduced 52.03%	363,969 $542,000
Q2 2024 Aug 14, 2024	BUY	$1.51 - $2.21 $155,951 - $228,246	103,279 Added 15.76%	758,740 $1.23 Million
Q1 2024 May 15, 2024	BUY	$1.51 - $3.12 $989,746 - $2.05 Million	655,461 New	655,461 $1.11 Million
Q2 2023 Aug 14, 2023	SELL	$3.94 - $6.27 $833,755 - $1.33 Million	-211,613 Reduced 61.85%	130,539 $817,000
Q1 2023 May 15, 2023	BUY	$4.77 - $9.16 $1.28 Million - $2.46 Million	268,615 Added 365.28%	342,152 $1.63 Million
Q4 2022 Feb 14, 2023	SELL	$8.17 - $12.95 $710,455 - $1.13 Million	-86,959 Reduced 54.18%	73,537 $640,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $1.83 Million - $2.76 Million	160,496 New	160,496 $1.91 Million
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $1.02 Million - $1.62 Million	-68,845 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$19.99 - $30.24 $1.38 Million - $2.08 Million	68,845 New	68,845 $1.59 Million
Q2 2021 Aug 16, 2021	SELL	$28.01 - $36.01 $211,755 - $272,235	-7,560 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$30.66 - $49.5 $231,789 - $374,220	7,560 New	7,560 $249,000
Q4 2020 Feb 16, 2021	SELL	$31.86 - $61.51 $8.93 Million - $17.2 Million	-280,425 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $9.96 Million - $10.7 Million	280,425 New	280,425 $9.96 Million

Others Institutions Holding PMVP

# of Institutions

Shares Held

41.9M

Call Options Held

3.1K

Put Options Held

1.7K

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $68.4M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account